Trial update: Cohort Study of HIV-positive People, Treated With Long Acting Antiretroviral Therapy (SCohoLART)

Trial Updat

A hospital-sponsored Ph4 trial collecting RWE for CAB+RPV in Milan has been initiated, with its PCD set for July 17, 2023 (NCT05663580). The study will continuously monitor incidence of VF and discontinuation as primary endpoints, while secondary endpoints will include safety, RAM emergence, metabolic factors, and patient satisfaction (12/23).

Additional information to the following link: https://clinicaltrials.gov/ct2/history/NCT05663580?A=1&B=1&C=Side-by-Side#StudyPageTop